Multi-Organ Chip: Liver First-Pass Cascade

What the Multi-Organ Chip Is

A multi-organ chip is an advanced microfluidic device that integrates multiple tissue models on a single platform, allowing for the study of complex physiological processes in vitro. The liver first-pass cascade within such a chip specifically simulates how drugs are metabolized by the liver before entering systemic circulation.

This technology combines principles from pharmacology and bioengineering to provide a more accurate representation of drug behavior compared to traditional in vivo or in vitro methods.

Why It Matters

The multi-organ chip, particularly the liver first-pass cascade, is crucial for understanding how drugs are processed by the body. By mimicking the physiological environment of a human liver, it allows researchers to predict drug metabolism and bioavailability with greater precision.

This technology can significantly reduce the need for animal testing and provide valuable insights into potential side effects before clinical trials.

live demo · related simulation● LIVE

The Michaelis-Menten Kinetics

In the liver first-pass cascade, enzymes in the liver follow Michaelis-Menten kinetics. This model describes how enzyme activity changes with substrate concentration and is given by Vmax/Km, where Vmax represents the maximum rate of reaction and Km is the substrate concentration at which the reaction rate is half of Vmax.

By adjusting these parameters through the chip's controls, researchers can study how different drug doses affect hepatic metabolism.

Real-World Applications

The multi-organ chip with its liver first-pass cascade has numerous applications in drug development. It helps in optimizing drug formulations, predicting pharmacokinetic profiles, and identifying potential toxicities.

This technology can also be used to study the effects of genetic variations on drug metabolism, leading to personalized medicine approaches.

Frequently asked questions

How does the liver first-pass cascade differ from other organ models in multi-organ chips?

The liver first-pass cascade is unique because it specifically focuses on the metabolic processes that occur when a drug enters the body through the gastrointestinal tract before reaching systemic circulation, which is not typically modeled by other organs.

What are some limitations of using multi-organ chips for studying pharmacokinetics?

While multi-organ chips offer significant improvements over traditional methods, they still have limitations such as the complexity of simulating all physiological conditions and the potential for differences in responses between in vitro and in vivo environments.

Can this technology be used to study other organs besides the liver?

Yes, multi-organ chips can incorporate models of various organs including the heart, lungs, kidneys, and intestines, allowing for a comprehensive study of drug distribution and metabolism across multiple organ systems.

How does the chip track hepatic extraction and systemic bioavailability?

The chip tracks hepatic extraction by measuring the amount of drug that is metabolized in the liver chamber. Systemic bioavailability is monitored by observing the surviving fraction of the drug as it flows into downstream target-organ chambers.

Try it live

Everything above runs in your browser — open Multi-Organ Chip: Liver First-Pass Cascade and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Multi-Organ Chip: Liver First-Pass Cascade simulation